PTC is committed to developing innovative therapies for rare diseases with high unmet medical need. For those living with phenylketonuria (PKU), current treatment options remain limited, making the need for individualized care more urgent than ever. ---- At PTC Therapeutics we're committed to a single purpose: Extending life’s moments for patients with rare diseases and their loved ones. As a patient-centric, global pharmaceutical company, we combine clinical and scientific expertise with groundbreaking science and technology, always with the patient in mind. What drives us is our passion to provide patients with more moments with their families. Learn more about our work at Find us on the web: Facebook: Instagram: X: LinkedIn: